ClinicalTrials.Veeva

Menu

Efficiency of an Optimized Care Organization for Fatigue Management for Patients With COVID-19. (CoviMouv)

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

COVID-19
Fatigue

Treatments

Other: Control
Other: CoviMouv' program

Study type

Observational

Funder types

Other

Identifiers

NCT05236478
IRBN142021/CHUSTE

Details and patient eligibility

About

Length of hospitalization for COVID-19 infection may be increased due to the persistence of fatigue in 29-46% of cases. Its management is essential to prevent the chronic fatigue . Chronic fatigue syndrome affected between 30 and 40% of patients with SARS in 2003 or MERS in 2005 and persisted beyond 3 years. There is currently no specific treatment for acute or <4 months asthenia. To avoid the transition to chronicity, some authors recommend respecting a long rest period. However, a program combining adapted physical activity and therapeutic patient education has already shown significant benefits for combating recent or semi-recent fatigue following a cardiovascular pathology and even during cancer treatments. Therefore, the existing care pathway for hospitalized patients with COVID-19 was adapted, combining exercise training and therapeutic patient education workshops.

Enrollment

17 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient living in the Loire region, France
  • Patient showing post COVID-19 fatigue (RT PCR positive <1 month)
  • Non-intubated patient if hospitalization in intensive care (<72h)
  • Patient hospitalized in a Covid unit at the Saint Etienne Hospital

Exclusion criteria

  • Patient hospitalized in intensive care >72h
  • Intubated and ventilated patient in intensive care
  • Non-hospitalized patient and community-based medical follow-up

Trial design

17 participants in 2 patient groups

CoviMouv' program
Description:
Patients who have benefited from the CoviMouv' program (supervised physical activity program + therapeutic education program) will be included.
Treatment:
Other: CoviMouv' program
control group
Description:
Patients with autonomous physical activity at home or with a community-based physiotherapist will be included. They will have support for the resumption of an adapted physical activity in autonomy, according to the results of the aerobic and anaerobic tests carried out during the initial evaluation (delivery of a training booklet).
Treatment:
Other: Control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems